Shasun Pharmaceuticals Ltd.[Merged] - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 15	Mar ' 14	Mar ' 13	Mar ' 12	Mar ' 11

Sales

1,078.40

934.72

782.76

735.91

567.85

Operating profit

112.90

89.45

68.13

51.52

39.16

Interest

45.61

35.62

26.49

30.48

21.50

Gross profit

81.21

66.10

55.30

62.00

32.11

EPS (Rs)

6.87

6.22

4.64

9.63

1.01

Other income

13.92

12.27

13.66

40.96

14.45

Stock adjustment

3.21

-29.34

-17.78

-1.14

-30.48

Raw material

619.45

560.85

500.97

465.51

381.28

Power and fuel

-

-

-

-

-

Employee expenses

114.11

95.26

76.74

59.52

50.85

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

228.73

218.50

154.70

160.50

127.04

Provisions made

-

-

-

-

-

Depreciation

36.85

38.15

31.66

24.73

24.22

Taxation

4.48

-7.28

-2.64

-15.79

3.01

Net profit / loss

41.34

35.23

26.28

53.06

4.88

Extra ordinary item

1.46

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

12.03

11.33

11.33

11.03

9.71

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

363.81

328.61

325.61

325.73

259.03

Agg.of non promotoholding (%)

60.51

58.03

57.50

59.09

53.36

OPM (%)

10.47

9.57

8.70

7.00

6.90

GPM (%)

7.43

6.98

6.94

7.98

5.51

NPM (%)

3.78

3.72

3.30

6.83

0.84